Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mecha

[1]  J. Baillie,et al.  SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses , 2022, The Lancet.

[2]  Sameer S. Kadri,et al.  Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021 , 2022, MMWR. Morbidity and mortality weekly report.

[3]  Yoon-Seok Chung,et al.  Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea , 2021, Viruses.

[4]  F. Ginhoux,et al.  Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis , 2021, Cell Death & Differentiation.

[5]  C. Prichard,et al.  Case series of acute appendicitis association with SARS-CoV-2 infection , 2021, BMC Infectious Diseases.

[6]  P. Gullón,et al.  Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors , 2021, European Journal of Cancer.

[7]  G. Benard,et al.  SARS-CoV-2 Infection and CMV Dissemination in Transplant Recipients as a Treatment for Chagas Cardiomyopathy: A Case Report , 2021, Tropical medicine and infectious disease.

[8]  H. Gouklani,et al.  Dysentery as the only presentation of COVID-19 in a child: a case report , 2021, Journal of Medical Case Reports.

[9]  E. Kandil,et al.  Gastroenterology manifestations and COVID‐19 outcomes: A meta‐analysis of 25,252 cohorts among the first and second waves , 2021, Journal of medical virology.

[10]  C. Vogels,et al.  Multiplexed RT-qPCR to screen for SARS-COV-2 B.1.1.7, B.1.351, and P.1 variants of concern v2 , 2021, protocols.io.

[11]  N. Okabe,et al.  Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient , 2020, Journal of Infection and Chemotherapy.

[12]  B. Cao,et al.  Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity , 2020, Clinical Microbiology and Infection.

[13]  M. Zapor.  Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients , 2020, Viruses.

[14]  Sathish Kandasamy.  An unusual presentation of COVID-19: Acute pancreatitis , 2020, Annals of hepato-biliary-pancreatic surgery.

[15]  S. Moonah,et al.  Acute appendicitis in four children with SARS-CoV-2 infection , 2020, Journal of Pediatric Surgery Case Reports.

[16]  S. Roll,et al.  COVID-19 and Cytomegalovirus Co-infection: A Challenging Case of a Critically Ill Patient with Gastrointestinal Symptoms. , 2020, European journal of case reports in internal medicine.

[17]  L. Khedmat,et al.  Iranian kidney transplant recipients with COVID‐19 infection: Clinical outcomes and cytomegalovirus coinfection , 2020, Transplant infectious disease : an official journal of the Transplantation Society.

[18]  A. Charlett,et al.  Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[19]  Shahzaib Ahmad,et al.  SARS–CoV-2 isolation from an appendix , 2020, Journal of surgical case reports.

[20]  Zeyu Chen,et al.  T cell responses in patients with COVID-19 , 2020, Nature Reviews Immunology.

[21]  Q. Ye,et al.  The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19 , 2020, American journal of physiology. Gastrointestinal and liver physiology.

[22]  H. Krumholz,et al.  Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.

[23]  G. Saeed,et al.  COVID-19-associated acute pancreatitis: a rare cause of acute abdomen , 2020, Radiology Case Reports.

[24]  J. Izbicki,et al.  TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer , 2020, Nature Communications.

[25]  S. Ng,et al.  Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis , 2020, The Lancet Gastroenterology & Hepatology.

[26]  B. Zhu,et al.  Co-infection with respiratory pathogens among COVID-2019 cases , 2020, Virus Research.

[27]  H. Goyal,et al.  COVID-19 presenting as acute pancreatitis , 2020, Pancreatology.

[28]  Hans Clevers,et al.  SARS-CoV-2 productively infects human gut enterocytes , 2020, Science.

[29]  Sunil Dolwani,et al.  Persistent viral shedding of SARS‐CoV‐2 in faeces – a rapid review , 2020, medRxiv.

[30]  Anthony T Debenedet,et al.  SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease , 2020, The American journal of gastroenterology.

[31]  Rong Lin,et al.  Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes , 2020, The American journal of gastroenterology.

[32]  D. Bernstein,et al.  COVID-19 Presenting as Acute Hepatitis , 2020, The American journal of gastroenterology.

[33]  Pibao Li,et al.  Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study , 2020, The American journal of gastroenterology.

[34]  A. Tam,et al.  Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis , 2020, Gastroenterology.

[35]  W. Nian,et al.  Review article: gastrointestinal features in COVID‐19 and the possibility of faecal transmission , 2020, Alimentary pharmacology & therapeutics.

[36]  Sunny H Wong,et al.  Covid‐19 and the digestive system , 2020, Journal of gastroenterology and hepatology.

[37]  Bing Han,et al.  COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission , 2020, Gastroenterology.

[38]  Jun Li,et al.  Clinical Features of COVID-19 Related Liver Damage , 2020, medRxiv.

[39]  H. Shan,et al.  Evidence for Gastrointestinal Infection of SARS-CoV-2 , 2020, Gastroenterology.

[40]  G. Dreyfuss,et al.  U1 snRNP regulates cancer cell migration and invasion , 2019, bioRxiv.

[41]  L. Chiche,et al.  Cytomegalovirus reactivation in ICU patients , 2015, Intensive Care Medicine.

[42]  A. Heim,et al.  Detection of cytomegalovirus (CMV) by real-time PCR in fecal samples for the non-invasive diagnosis of CMV intestinal disease. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[43]  A. Ahmed.  Immunopathology of CMV Co-Infection: Review , 2014 .

[44]  B. McSharry,et al.  Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus , 2014, Front. Microbiol..

[45]  Y. Tan,et al.  [Role of Treg/Th17 balance in the pathogenesis of cytomegalovirus infection]. , 2012, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[46]  P. Massip,et al.  Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. , 2012, The Journal of clinical investigation.

[47]  T. Naoe,et al.  Correlation of Serum IL-6 Level with Exhaustion of Cytomegalovirus-specific T Cells After Hematopoietic Stem Cell Transplantation , 2011 .

[48]  T. Sparer,et al.  Feeling manipulated: cytomegalovirus immune manipulation , 2009, Virology Journal.

[49]  T. Shenk,et al.  Human cytomegalovirus genome. , 2008, Current topics in microbiology and immunology.

[50]  T. Mertens,et al.  Cellular immunity and active human cytomegalovirus infection in patients with septic shock. , 2007, The Journal of infectious diseases.

[51]  D. Levy,et al.  IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways , 2007, Nature Immunology.

[52]  R. Myers,et al.  Coding potential of laboratory and clinical strains of human cytomegalovirus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  V. Štolc,et al.  Functional profiling of a human cytomegalovirus genome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[55]  M. Abecassis,et al.  A model for reactivation of CMV from latency. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[56]  D. Michel,et al.  Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples , 1995, Journal of clinical microbiology.

[57]  H. Volk,et al.  Cytomegalovirus reactivation and tumour necrosis factor , 1994, The Lancet.